Anthony Cerami
Directeur Général chez Warren Pharmaceuticals, Inc.
Profil
Anthony Cerami is the founder of Warren Pharmaceuticals, Inc. (founded in 2001) where he holds the title of Chief Executive Officer starting in 2012.
He is also the founder of Araim Pharmaceuticals, Inc. (founded in 2006) where he holds the title of Director-Emeritus starting in 2006.
Currently, Dr. Cerami is a Member at the National Academy of Sciences.
In the past, he worked as a Dean at The Rockefeller University.
Dr. Cerami obtained his doctorate degree from The Rockefeller University in 1967.
Postes actifs de Anthony Cerami
| Sociétés | Poste | Début |
|---|---|---|
Warren Pharmaceuticals, Inc.
 Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Directeur Général | 17/05/2001 |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | 18/08/2009 |
Araim Pharmaceuticals, Inc.
 Araim Pharmaceuticals, Inc. BiotechnologyHealth Technology Araim Pharmaceuticals, Inc. operates as a biotechnology company that develops novel treatments for devastating injuries and chronic diseases. It provides ARA 290, a novel 11 amino acid peptide that activates the body’s natural repair system through the innate repair receptor, which is present only following injury, as well as activates anti-inflammatory, tissue protective, and reparative signaling pathways. The company was founded by Anthony Cerami and Michael Brines in 2006 and is headquartered in Tarrytown, NY. | Fondateur | 01/01/2006 |
Anciens postes connus de Anthony Cerami
| Sociétés | Poste | Fin |
|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | - |
Formation de Anthony Cerami
| The Rockefeller University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Warren Pharmaceuticals, Inc.
Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
Araim Pharmaceuticals, Inc.
Araim Pharmaceuticals, Inc. BiotechnologyHealth Technology Araim Pharmaceuticals, Inc. operates as a biotechnology company that develops novel treatments for devastating injuries and chronic diseases. It provides ARA 290, a novel 11 amino acid peptide that activates the body’s natural repair system through the innate repair receptor, which is present only following injury, as well as activates anti-inflammatory, tissue protective, and reparative signaling pathways. The company was founded by Anthony Cerami and Michael Brines in 2006 and is headquartered in Tarrytown, NY. | Health Technology |
